Inflammatory bowel diseases: a dysfunction of brain-gut interactions?

Area of Science:

• Neurogastroenterology
• Immunology
• Microbiome Research

Background:

• The gut communicates with the central nervous system via the autonomic nervous system (ANS), including sympathetic and parasympathetic pathways.
• The brain integrates gut signals through a central autonomic network and influences the ANS and hypothalamic pituitary adrenal (HPA) axis.
• Dysfunctional brain-gut interactions are observed in irritable bowel syndrome (IBS) and are increasingly recognized in inflammatory bowel diseases (IBD).

Purpose of the Study:

• To review current knowledge on the role of brain-gut interaction dysfunction in the pathogenesis of IBD.
• To explore specific mechanisms including ANS dysfunction, HPA axis abnormalities, and the impact of stress and depression.
• To examine the influence of the microbiota-brain axis and prefrontal cortex-amygdala coupling in IBD.

Main Methods:

• Literature review of studies investigating brain-gut axis in IBD.
• Analysis of the role of autonomic nervous system (ANS) and hypothalamic pituitary adrenal (HPA) axis.
• Examination of psychological factors (stress, depression) and microbiota-gut-brain axis.

Main Results:

• Evidence suggests ANS dysfunction, altered HPA axis activity, and impaired cholinergic anti-inflammatory pathways in IBD.
• Stress and depression exacerbate IBD pathogenesis through disrupted brain-gut signaling.
• Abnormalities in prefrontal cortex-amygdala coupling and microbiota composition contribute to inflammation.

Conclusions:

• Brain-gut interaction dysfunction is a significant factor in IBD pathogenesis.
• Targeting the brain-gut axis, including the ANS, HPA axis, and microbiota, holds therapeutic potential for IBD.
• Restoring equilibrium in brain-gut communication is a promising avenue for IBD management.